Top Story

Human Rights Campaign endorses Truvada for PrEP treatment

October 25, 2014

The Human Rights Campaign has endorsed the use of emtricitabine plus tenofovir disoproxil fumarate for pre-exposure prophylaxis, according to an HRC policy paper.

Emtricitabine/tenofovir disoproxil fumarate (Truvada, Gilead Sciences) previously had been supported by the CDC and WHO, as well as AIDS United and the Gay Men’s Health Crisis Center. The HRC is the largest civil rights organization for lesbian, gay, bisexual and transgender individuals, the demographics most at risk for HIV infection. Currently, Truvada is the only brand name anti-HIV treatment approved for PrEP, according to a related press release.

Mali confirms child as country's first Ebola case

October 24, 2014
Mali’s ministry of health confirmed today that a female patient aged 2 years is the country’s first Ebola case, according to a WHO press release. The…
figure

Texas nurse declared Ebola-free, discharged from NIH Clinical Center

October 24, 2014
The first nurse from Texas Health Presbyterian Hospital in Dallas who became infected with Ebola while caring for the first case in the United States has been declared…
figure Meeting News CoverageVideo

Fresh, frozen or lyophilized FMT via colonoscopy effectively treated recurrent CDI

October 24, 2014
PHILADELPHIA — Zhi-Dong Jiang, MD, DrPh, of the University of Texas School of Public Health, discusses the findings from her study of the efficacy of fresh…
More News Headlines »
Editorial
figure

Managing the threat of untreatable gonorrhea

Infectious Disease News, September 2014
Stephanie Chisholm; Gwenda Hughes, BA(Hons), PhD, FFPH; Kevin A. Fenton, MD, PhD, FFPH
Gonorrhea is a sexually transmitted infection that can lead to serious reproductive tract morbidity if untreated and…
More »
Blog

Rabies, raccoons and renal transplantation

March 28, 2013
After spending the good part of my Friday lunch break regaling the ebullient staff writer from The Toronto Star
More »
Meeting News Coverage Video
figure

Fresh, frozen or lyophilized FMT via colonoscopy effectively treated recurrent CDI

October 24, 2014
PHILADELPHIA — Zhi-Dong Jiang, MD, DrPh, of the University of Texas School of Public Health, discusses the…
More »